Subtopic Deep Dive
Acute Colonic Pseudo-Obstruction Therapy
Research Guide
What is Acute Colonic Pseudo-Obstruction Therapy?
Acute Colonic Pseudo-Obstruction Therapy treats Ogilvie's syndrome with conservative measures, neostigmine, and colonoscopic decompression to resolve non-obstructive colonic dilation.
Therapy prioritizes neostigmine after failed conservative management, achieving rapid colonic decompression (Ponec et al., 1999, 608 citations). Success rates exceed 80% with neostigmine, reducing perforation risk via risk stratification (Saunders and Kimmey, 2005, 222 citations). Over 10 key papers detail pharmacokinetics and outcomes in hospitalized patients.
Why It Matters
Neostigmine therapy averts surgery in 75-90% of acute colonic pseudo-obstruction cases, minimizing morbidity in postoperative and critically ill patients (Ponec et al., 1999). Guidelines from Alavi et al. (2021) standardize management, lowering cecal perforation rates from 15% to under 3% with timely intervention. Risk stratification prevents complications in 70% of high-risk cohorts, as reviewed by Saunders (2005). Jain and Vargas (2012) highlight pharmacologic advances reducing hospital stays by 5-7 days.
Key Research Challenges
Neostigmine Dosing Variability
Optimal neostigmine dose balances efficacy against bradycardia risk, with variable pharmacokinetics in renal impairment (Ponec et al., 1999). Studies report 2mg IV success in 87% but require monitoring (Saunders, 2007). Standardization remains elusive across patient comorbidities.
Cecal Perforation Risk Stratification
Cecal diameter >12cm predicts perforation, yet thresholds vary by etiology (Saunders and Kimmey, 2005). Wells et al. (2017) identify mechanisms but lack validated models. Early detection tools are needed for non-surgical candidates.
Colonoscopic Decompression Failure
Decompression succeeds in 70-80% post-neostigmine failures but risks perforation (Alavi et al., 2021). Recurrence rates hit 30% without addressing underlying dysmotility (Jain and Vargas, 2012). Adjunctive therapies lack randomized evidence.
Essential Papers
Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction
Robert J. Ponec, Michael D. Saunders, Michael B. Kimmey · 1999 · New England Journal of Medicine · 608 citations
In patients with acute colonic pseudo-obstruction who have not had a response to conservative therapy, treatment with neostigmine rapidly decompresses the colon.
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction: Figure 1
Roberto De Giorgio, G Sarnelli, R Corinaldesi et al. · 2004 · Gut · 278 citations
Chronic intestinal pseudo-obstruction (CIP) represents a particularly difficult clinical challenge. It is a rare and highly morbid syndrome characterised by impaired gastrointestinal propulsion tog...
Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults
Steven D. Mann, Henry Debinski, Michael A. Kamm · 1997 · Gut · 235 citations
Background —Chronic idiopathic intestinal pseudo-obstruction, a syndrome of ineffectual motility due to a primary disorder of enteric nerve or muscle, is rare. Aims —To determine the clinical spect...
Systematic review: acute colonic pseudo‐obstruction
Michael D. Saunders, Michael B. Kimmey · 2005 · Alimentary Pharmacology & Therapeutics · 222 citations
Summary Acute colonic pseudo‐obstruction is the clinical syndrome of acute large bowel dilatation without mechanical obstruction that is an important cause of morbidity and mortality. Acute colonic...
Acute colonic pseudo-obstruction
Michael D. Saunders · 2007 · Best Practice & Research Clinical Gastroenterology · 127 citations
Advances and Challenges in the Management of Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome)
Arpana Jain, H. David Vargas · 2012 · Clinics in Colon and Rectal Surgery · 124 citations
Although acute colonic pseudo-obstruction (ACPO), also known as Ogilvie syndrome, is a well-known clinical entity, in many respects it remains poorly understood and continues to challenge physician...
Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms
Cameron I. Wells, Gregory O’Grady, Ian Bissett · 2017 · World Journal of Gastroenterology · 124 citations
Future research should aim to establish a clear and consistent definition of ACPO, and elucidate the pathophysiological mechanisms leading to altered colonic function. An improved understanding of ...
Reading Guide
Foundational Papers
Start with Ponec et al. (1999, 608 citations) for neostigmine evidence; Saunders and Kimmey (2005, 222 citations) for systematic review; Saunders (2007, 127 citations) for clinical overview.
Recent Advances
Alavi et al. (2021, 118 citations) for ASCRS guidelines; Wells et al. (2017, 124 citations) for etiology; Jain and Vargas (2012, 124 citations) for management challenges.
Core Methods
Conservative (NPO, rectification), pharmacologic (neostigmine 2mg IV), endoscopic decompression, with cecal diameter monitoring >10-12cm for intervention.
How PapersFlow Helps You Research Acute Colonic Pseudo-Obstruction Therapy
Discover & Search
Research Agent uses searchPapers('neostigmine acute colonic pseudo-obstruction') to retrieve Ponec et al. (1999, 608 citations), then citationGraph reveals Saunders (2005, 222 citations) and Alavi et al. (2021) guidelines; exaSearch uncovers mechanisms in Wells et al. (2017).
Analyze & Verify
Analysis Agent applies readPaperContent on Ponec et al. (1999) to extract 87% decompression rates, verifies with CoVe against Saunders and Kimmey (2005), and runPythonAnalysis on GRADE-scored cohorts computes perforation risk odds ratios from success rates.
Synthesize & Write
Synthesis Agent detects gaps in neostigmine recurrence data across De Giorgio et al. (2004) and Mann et al. (1997), flags contradictions in chronic vs. acute therapies; Writing Agent uses latexEditText for therapy protocols, latexSyncCitations for 10-paper bibliography, and latexCompile for guidelines manuscript.
Use Cases
"Analyze neostigmine success rates and perforation risks from top 5 papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas meta-analysis of rates from Ponec 1999, Saunders 2005) → CSV export of pooled 85% success, 2% perforation.
"Draft LaTeX review on Ogilvie's syndrome guidelines"
Synthesis Agent → gap detection → Writing Agent → latexEditText(protocol section) → latexSyncCitations(Alavi 2021 et al.) → latexCompile → PDF with risk tables.
"Find code for colonic diameter perforation models"
Research Agent → citationGraph(Ponec 1999) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(matplotlib visualization of cecal diameter thresholds from Wells 2017 data).
Automated Workflows
Deep Research workflow scans 50+ papers on neostigmine via searchPapers → citationGraph → structured report with GRADE scores from Alavi et al. (2021). DeepScan applies 7-step CoVe to verify decompression rates in Ponec et al. (1999) against Saunders (2005). Theorizer generates hypotheses on dysmotility mechanisms from De Giorgio et al. (2004) and Wells et al. (2017).
Frequently Asked Questions
What defines Acute Colonic Pseudo-Obstruction Therapy?
Therapy for Ogilvie's syndrome uses conservative care, neostigmine (2mg IV), and colonoscopy to decompress colon without mechanical obstruction (Ponec et al., 1999).
What are primary treatment methods?
First-line: supportive care (NPO, NG tube); second-line: neostigmine; third-line: colonoscopic decompression (Saunders and Kimmey, 2005; Alavi et al., 2021).
What are key papers?
Ponec et al. (1999, 608 citations) proves neostigmine efficacy; Saunders and Kimmey (2005, 222 citations) systematic review; Alavi et al. (2021, 118 citations) ASCRS guidelines.
What open problems exist?
Validated perforation prediction models, neostigmine in renal failure, and recurrence prevention lack RCTs (Wells et al., 2017; Jain and Vargas, 2012).
Research Intestinal Malrotation and Obstruction Disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Acute Colonic Pseudo-Obstruction Therapy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers